Pharmaceutical

Sanofi signs $1.2bn licensing agreement for Novavax’s Covid-19 vaccine

Sanofi has signed a $1.2bn licensing agreement with Novavax to co-commercialise its stand-alone adjuvanted Covid-19 vaccine.

May 11, 2024 - 04:00
Sanofi signs $1.2bn licensing agreement for Novavax’s Covid-19 vaccine
Sanofi has signed a $1.2bn licensing agreement with Novavax to co-commercialise its stand-alone adjuvanted Covid-19 vaccine.
Read the original article

Tags:

Previous Article

“What was that?” — How brains convert sounds to actions

Next Article

RAPT terminates Phase II trials for lead candidate following clinical hold

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Lilly partners with Haya for lncRNA obesity target deal worth $1bn

Lilly partners with Haya for lncRNA obesity target deal...

Sep 6, 2024

Innate shelves lacutamab monotherapy plans in peripheral T cell lymphoma

Innate shelves lacutamab monotherapy plans in periphera...

Mar 24, 2024

STAT+: Eli Lilly’s Mounjaro succeeds in second weight loss study, paving way for FDA review

STAT+: Eli Lilly’s Mounjaro succeeds in second weight l...

Apr 27, 2023